Trial Information
Current as of April 24, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \>18
- • Able and willing to complete exams
- • Patients in retina clinic that need angiography
- Exclusion Criteria:
- • Unable to complete the required examinations and visits
- • Large amount of subretinal hemorrhage
- • Media opacity leading to poor quality images
- • Extreme refractive error leading to poor quality images
- • Pathologies in the anterior segment leading to poor quality images
About Optovue
Optovue is a leading innovator in the field of ophthalmic imaging and diagnostics, specializing in advanced optical coherence tomography (OCT) technology. With a commitment to enhancing vision health, Optovue develops cutting-edge tools that empower healthcare professionals to detect and monitor ocular conditions with precision and efficiency. The company's clinical trials aim to validate the efficacy and safety of its groundbreaking solutions, contributing to improved patient outcomes and advancing the standard of care in ophthalmology. Through rigorous research and a dedication to innovation, Optovue strives to transform the landscape of eye care and promote a deeper understanding of eye diseases.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
